Solutions · Cell Therapy
Cell therapy research.
Cell therapy research at ExoBioCorp covers preclinical-stage research-supply for three domains: hematopoietic cellular therapy, immunotherapy, and regenerative medicine. All materials are For Research Use Only — not for clinical manufacturing, not for human administration, not for therapeutic substitution.
Hematopoietic Cellular Therapy
HSC-relevant research material for engraftment, expansion, and cellular-therapy method development.
Read more →Immunotherapy
Immune-cell starting material and conditioning serum for T-cell, NK-cell, and macrophage-relevant research.
Read more →Regenerative Medicine
MSC, MSC-EV, and donor-source preparations for regenerative-mechanism preclinical research.
Read more →For Research Use Only. ExoBioCorp products in this category are intended for non-clinical, in-vitro research by qualified scientific personnel. Not for clinical-cell-therapy manufacturing or human administration. Read the full RUO statement.